Parsian M1, Mutlu P2, Yalcin S3, Tezcaner A4, Gunduz U5.
Int J Pharm. 2016 Dec 30;515(1-2):104-113. doi: 10.1016/j.ijpharm.2016.10.015. Epub 2016 Oct 7.Tumor-specific delivery of anticancer drugs by magnetic nanoparticles will maximize the efficacy of the drug and minimize side effects, and reduce systemic toxicity. The magnetic core of these nanoparticles provides an advantage for selective drug targeting as they can be targeted to the tumor site and accumulated in cancer cells by means of an external magnetic field. Magnetic nanoparticles can be coated with Polyamidoamine (PAMAM) dendrimer and loaded with drugs. Read More